Corrigendum: "CK2: The master regulator in tumor immune-microenvironment - A crucial target in oncotherapy" [10.1016/j.ejphar.2025.177376].

Karmakar S, Chatterjee M, Basu M, Ghosh MK

Open source

DOI
10.1016/j.ejphar.2026.179341
Published
2026 Sep 18
Container
European journal of pharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejphar.2026.179341,
  title = {Corrigendum: "CK2: The master regulator in tumor immune-microenvironment - A crucial target in oncotherapy" [10.1016/j.ejphar.2025.177376].},
  author = {Karmakar S and Chatterjee M and Basu M and Ghosh MK},
  year = {2026},
  journal = {European journal of pharmacology},
  doi = {10.1016/j.ejphar.2026.179341},
  url = {https://doi.org/10.1016/j.ejphar.2026.179341}
}

RIS

TY  - JOUR
TI  - Corrigendum: "CK2: The master regulator in tumor immune-microenvironment - A crucial target in oncotherapy" [10.1016/j.ejphar.2025.177376].
AU  - Karmakar S
AU  - Chatterjee M
AU  - Basu M
AU  - Ghosh MK
PY  - 2026
JO  - European journal of pharmacology
DO  - 10.1016/j.ejphar.2026.179341
UR  - https://doi.org/10.1016/j.ejphar.2026.179341
ER  - 

APA

S, K., M, C., M, B., & MK, G. (2026). Corrigendum: "CK2: The master regulator in tumor immune-microenvironment - A crucial target in oncotherapy" [10.1016/j.ejphar.2025.177376].. European journal of pharmacology. https://doi.org/10.1016/j.ejphar.2026.179341

Source records